September 16, 2024

Supplemental Figure 8 from Myosin light chain kinase inhibition potentiates the anti-tumor effects of avapritinib in PDGFRA D842V-mutant gastrointestinal stromal tumor

Los puntos clave no están disponibles para este artículo en este momento.

Supplemental Figure 8. Relative MYLK mRNA expression by qPCR in GIST PDGFRA D842V PDXs treated with vehicle (Veh) or imatinib (IM) for 2 weeks.

Me gusta

Guardar

Cite This Study

Rossi et al. (Mon,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Me gusta

Guardar